Why Palantir’s health tech is not the right fit for the NHS | Letter

The news that NHS England may have overstated the benefits of Palantir for improving efficiency will surprise few frontline clinicians (NHS England deletes 'misleading' claim 137 trusts benefiting from Palantir AI tools, 12 November)

Too often, global digital policy assumes that software designed for the fragmented, insurance-based US healthcare system can simply be adapted to a universal public service elsewhere. A legitimate concern is that algorithms underpinning AI decision-making may be immature in the NHS context, having been developed primarily for a very different US healthcare system.

A consultant in a local trust recently described having to work across seven bolt-on software systems for a single consultation, including one focused on billing functions. A senior US hospital administrator explained that the primary purpose of most US health data systems was to record care for reimbursement. He was astounded that, by contrast, NHS general practice records are designed to support lifelong patient care and safe prescribing, with an NHS app similarly focused on a coded healthcare rather than how much of an insurance allowance had been used up that year.

We should also ask why the NHS needs a US firm to manage its data when the UK has a strong record of healthcare-software innovation. Emis, developed with GP leadership, transformed primary care IT decades ago. Software built for an insurance market may simply not be the best fit for universal healthcare systems.

GP, Sheffield, and professor of general practice research, Keele University

Original source Why Palantir’s health tech is not the right fit for the NHS | Letter

Back to home